share_log

HC Wainwright & Co. Maintains Buy on TC BioPharm (Holdings), Lowers Price Target to $7

HC Wainwright & Co. Maintains Buy on TC BioPharm (Holdings), Lowers Price Target to $7

HC Wainwright & Co.維持對TC BioPharm(Holdings)的買入,將目標股價下調至7美元
Benzinga ·  2023/04/27 06:29

HC Wainwright & Co. analyst Mitchell Kapoor maintains TC BioPharm (Holdings) (NASDAQ:TCBP) with a Buy and lowers the price target from $9 to $7.

HC Wainwright&Co.分析師米切爾·卡普爾維持TC BioPharm(Holdings:TCBP)的買入立場,並將目標價從9美元下調至7美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論